Long-term Visual Outcomes of Intravitreal Bevacizumab in Inflammatory Ocular Neovascularization

Intravitreal bevacizumab led in the long-term to significant mean visual improvement of ≥2.2 lines and significant foveal flattening in a wide variety of inflammatory ocular diseases without major complications.